The Journal of Immunology, Vol 154, Issue 9 4495-4502, Copyright © 1995 by American Association of Immunologists

ARTICLES

Tissue distribution of natural peptides derived from a ubiquitous dehydrogenase, including a novel liver-specific peptide that demonstrates the pronounced specificity of low affinity T cell reactions

MX Wu, TJ Tsomides and HN Eisen
Department of Biology, Massachusetts Institute of Technology, Cambridge 02139, USA.

The peptides recognized by CD8+ CTL normally arise by proteolysis of intracellular proteins. To learn whether these peptides are generated similarly in diverse cell types, we examined the variety and abundance of naturally processed peptides that derive from a ubiquitous enzyme, alpha-ketoglutarate dehydrogenase, and are recognized in association with the class I MHC protein, Ld, by a CTL clone (2C). A characteristic set of three peptides was found in diverse tissues, but their abundance varied greatly, apparently unrelated to differences in class I MHC expression, e.g., they were surprisingly abundant in liver. We also found in liver a fourth naturally processed peptide (p2Ca-Y4, LSPYPFDL) that differs by one oxygen atom from a previously characterized natural peptide (p2Ca, LSPFPFDL). CTL discrimination between these peptides in association with the same class I MHC protein, Kb, demonstrates the striking specificity that can be exhibited by low affinity T cell reactions.

This article has been cited by other articles:

				Q. Leng, Q. Ge, T. Nguyen, H. N. Eisen, and J. Chen Stage-dependent reactivity of thymocytes to self-peptide-MHC complexes PNAS, March 20, 2007; 104(12): 5038 - 5043. [Abstract] [Full Text] [PDF]

				V. Ramakrishna, M. M. Ross, M. Petersson, C. C. Gatlin, C. E. Lyons, C. L. Miller, H. E. Myers, M. McDaniel, L. R. Karns, R. Kiessling, et al. Naturally occurring peptides associated with HLA-A2 in ovarian cancer cell lines identified by mass spectrometry are targets of HLA-A2-restricted cytotoxic T cells Int. Immunol., June 1, 2003; 15(6): 751 - 763. [Abstract] [Full Text] [PDF]

				S. Kageyama, T. J. Tsomides, N. Fukusen, I. A. Papayannopoulos, H. N. Eisen, and Y. Sykulev Potent Cytolytic Response by a CD8+ CTL Clone to Multiple Peptides from the Same Protein in Association with an Allogeneic Class I MHC Molecule J. Immunol., March 1, 2001; 166(5): 3028 - 3034. [Abstract] [Full Text] [PDF]

				Y. Oka, K. Udaka, A. Tsuboi, O. A. Elisseeva, H. Ogawa, K. Aozasa, T. Kishimoto, and H. Sugiyama Cancer Immunotherapy Targeting Wilms' Tumor Gene WT1 Product J. Immunol., February 15, 2000; 164(4): 1873 - 1880. [Abstract] [Full Text] [PDF]

				B. Motyka and H.-S. Teh Naturally Occurring Low Affinity Peptide/MHC Class I Ligands Can Mediate Negative Selection and T Cell Activation J. Immunol., January 1, 1998; 160(1): 77 - 86. [Abstract] [Full Text] [PDF]

				M. Wick, P. Dubey, H. Koeppen, C. T. Siegel, P. E. Fields, L. Chen, J. A. Bluestone, and H. Schreiber Antigenic Cancer Cells Grow Progressively in Immune Hosts without Evidence for T Cell Exhaustion or Systemic Anergy J. Exp. Med., July 21, 1997; 186(2): 229 - 238. [Abstract] [Full Text] [PDF]

				S. Malarkannan, T. Serwold, V. Nguyen, L. A. Sherman, and N. Shastri The mouse mammary tumor virus env gene is the source of a CD8+ T-cell-stimulating peptide presented by a major histocompatibility complex class I molecule in a murine thymoma PNAS, November 26, 1996; 93(24): 13991 - 13996. [Abstract] [Full Text] [PDF]